By Greg Ryan ( October 15, 2013, 5:55 PM EDT) -- The U.S. Supreme Court on Tuesday declined to review the Eleventh Circuit's ruling that Hospira Inc. had no special duty to a proposed class of patients to supply an injectable form of vitamin A, even if it was the drug's only manufacturer....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.